Shilpa Medicare Ltd
NSE:SHILPAMED

Watchlist Manager
Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd
NSE:SHILPAMED
Watchlist
Price: 766.65 INR -1.48% Market Closed
Market Cap: 75B INR
Have any thoughts about
Shilpa Medicare Ltd?
Write Note

Shilpa Medicare Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shilpa Medicare Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Shilpa Medicare Ltd
NSE:SHILPAMED
Total Other Income
â‚ą188.6m
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
11%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Other Income
â‚ą9.1B
CAGR 3-Years
25%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Other Income
â‚ą7.8B
CAGR 3-Years
42%
CAGR 5-Years
17%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Other Income
â‚ą15.8B
CAGR 3-Years
25%
CAGR 5-Years
12%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Other Income
â‚ą942.9m
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
-4%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Other Income
â‚ą768.7m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shilpa Medicare Ltd
Glance View

Market Cap
75B INR
Industry
Pharmaceuticals

Shilpa Medicare Ltd. engages in the manufacturing of pharmaceutical product and wind power generation. The company is headquartered in Raichur, Karnataka. The firm is engaged in manufacturing active pharmaceutical ingredients (APIs), formulation and development service. The company is focused on new drug delivery systems, peptides/biotech products and specialty chemicals. The Company’s product range include oncology and non-oncology APIs, oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. The company supplies oncology/non-oncology APIs and intermediates. Its oncology APIs products include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India.

SHILPAMED Intrinsic Value
1 131.61 INR
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Shilpa Medicare Ltd's Total Other Income?
Total Other Income
188.6m INR

Based on the financial report for Sep 30, 2024, Shilpa Medicare Ltd's Total Other Income amounts to 188.6m INR.

What is Shilpa Medicare Ltd's Total Other Income growth rate?
Total Other Income CAGR 10Y
11%

Over the last year, the Total Other Income growth was 118%.

Back to Top